drugset / Trial / NCT01225315
Clinical Study to Explore the Efficacy of ACT-129968 in Patients With Partly Controlled Asthma
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will assess the efficacy and safety of ACT-129968 in subjects with partly controlled asthma on reliever therapy only.
Timeline
- Start
- 2010-11-01
- Primary completion
- 2012-01-01
- Completion
- 2012-02-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Setipiprant | Small molecule | 100 mg | Oral |
| Subject | Setipiprant | Small molecule | 500 mg | Oral |
| Subject | Setipiprant | Small molecule | 1000 mg | Oral |